Sarah M. Talib, Adawiya J. Haider, Sharafaldin Al-Musawi, Fawwaz Shakir Al-Joudi, Suhair A. Ahmed
{"title":"Laser-fabricated Metal Oxide Core–shell Nanoparticles for Biomedical Applications: a Mini Review","authors":"Sarah M. Talib, Adawiya J. Haider, Sharafaldin Al-Musawi, Fawwaz Shakir Al-Joudi, Suhair A. Ahmed","doi":"10.1007/s11468-024-02469-0","DOIUrl":null,"url":null,"abstract":"<div><p>Core–shell nanoparticles prepared by pulsed laser ablation in liquid (PLAL) offer a revolutionary approach to medical treatment, boasting versatile properties that enable precise drug delivery and early disease detection. With the integration of therapeutic and diagnostic capabilities, known as theragnostic, these nanoparticles allow real-time monitoring of treatment response. Their biocompatibility, stability, and multifunctionality make them cutting-edge tools in modern medicine, addressing challenges in drug delivery, imaging, and targeted therapy for improved patient outcomes. In medical applications, drug delivery is a key area of research and utilization for core–shell nanoparticles. Engineered to encapsulate therapeutic agents within their core and coated with a responsive shell, these nanoparticles enable controlled drug release at targeted sites, enhancing efficacy while minimizing side effects. Core–shell nanoparticles hold the potential to improve drug solubility, prolong circulation time, and customize drug release kinetics, making them adaptable to various therapeutic needs, from cancer therapy to chronic disease management. PLAL has emerged as a vital technique for manufacturing core–shell nanoparticles because of its unique advantages. By irradiating a target material with a pulsed laser beam in a liquid environment, PLAL enables precise nanoparticle generation with tailored size, morphology, and composition. This technique offers a scalable approach for synthesizing core–shell nanoparticles, allowing for the encapsulation of different materials within a protective shell. PLAL also facilitates the incorporation of functional coatings, enhancing nanoparticle properties and functionalities for diverse medical applications such as drug delivery, imaging, and catalysis. With its ability to produce tailored nanoparticles with high purity and reproducibility, PLAL holds promise for advancing the development of next-generation core–shell nanomaterials.</p></div>","PeriodicalId":736,"journal":{"name":"Plasmonics","volume":"20 9","pages":"7509 - 7526"},"PeriodicalIF":4.3000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Plasmonics","FirstCategoryId":"101","ListUrlMain":"https://link.springer.com/article/10.1007/s11468-024-02469-0","RegionNum":4,"RegionCategory":"物理与天体物理","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, PHYSICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Core–shell nanoparticles prepared by pulsed laser ablation in liquid (PLAL) offer a revolutionary approach to medical treatment, boasting versatile properties that enable precise drug delivery and early disease detection. With the integration of therapeutic and diagnostic capabilities, known as theragnostic, these nanoparticles allow real-time monitoring of treatment response. Their biocompatibility, stability, and multifunctionality make them cutting-edge tools in modern medicine, addressing challenges in drug delivery, imaging, and targeted therapy for improved patient outcomes. In medical applications, drug delivery is a key area of research and utilization for core–shell nanoparticles. Engineered to encapsulate therapeutic agents within their core and coated with a responsive shell, these nanoparticles enable controlled drug release at targeted sites, enhancing efficacy while minimizing side effects. Core–shell nanoparticles hold the potential to improve drug solubility, prolong circulation time, and customize drug release kinetics, making them adaptable to various therapeutic needs, from cancer therapy to chronic disease management. PLAL has emerged as a vital technique for manufacturing core–shell nanoparticles because of its unique advantages. By irradiating a target material with a pulsed laser beam in a liquid environment, PLAL enables precise nanoparticle generation with tailored size, morphology, and composition. This technique offers a scalable approach for synthesizing core–shell nanoparticles, allowing for the encapsulation of different materials within a protective shell. PLAL also facilitates the incorporation of functional coatings, enhancing nanoparticle properties and functionalities for diverse medical applications such as drug delivery, imaging, and catalysis. With its ability to produce tailored nanoparticles with high purity and reproducibility, PLAL holds promise for advancing the development of next-generation core–shell nanomaterials.
期刊介绍:
Plasmonics is an international forum for the publication of peer-reviewed leading-edge original articles that both advance and report our knowledge base and practice of the interactions of free-metal electrons, Plasmons.
Topics covered include notable advances in the theory, Physics, and applications of surface plasmons in metals, to the rapidly emerging areas of nanotechnology, biophotonics, sensing, biochemistry and medicine. Topics, including the theory, synthesis and optical properties of noble metal nanostructures, patterned surfaces or materials, continuous or grated surfaces, devices, or wires for their multifarious applications are particularly welcome. Typical applications might include but are not limited to, surface enhanced spectroscopic properties, such as Raman scattering or fluorescence, as well developments in techniques such as surface plasmon resonance and near-field scanning optical microscopy.